近视乐品牌怎么样 申请店铺

我要投票 近视乐在滴眼液行业中的票数:447 更新时间:2025-09-22
近视乐是哪个国家的品牌?「近视乐」是 大理白族自治州中药制药有限公司 旗下著名品牌。该品牌发源于云南省大理白族自治州,由创始人朱 * 在1969年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力近视乐品牌出海!将品牌入驻外推网,定制近视乐品牌推广信息,可以显著提高近视乐产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

近视乐怎么样

用大理地区主产的白族药紫坚伦为主要原料生产的近视乐眼药水业界知名,全国民族用品定点生产企业。

1969 年始建于云贵高原之南的具有 “ 风花雪月 ” 美称的大理白族自治州境内的大理白族自治州中药制药有限公司,前身是大理白族自治州中药制药厂。2002 年改制为由董事长控股经营的有限责任公司。

2003年12月通过GMP认证验收,企业占地15000 余平方米,达到GMP的净化生产车间1950平方米,仓库的建筑面积 8000 多平方米。企业信用等级经银行认定达 AA 级。企业现有在职员工近 200 人,退休职工 31 人,在职员工中有技术人员 36 人,其中有高级制药工程师 3 人,工程师级 15 人。

2008年12月顺利通过第二轮GMP认证验收。本次认证验收前我公司一方面又投入大量资金对厂房、设备进行改造、引进,第二方面着重对软件部分进行深入调整、改进,使之更加具有可操作性。

公司现有经国家药监局批准注册的国药准字号品种 43 个,分属于片剂、酊剂、滴眼剂、胶囊剂、糖浆剂、软膏剂、散剂、酒剂、颗粒剂九个剂型,产品注册商标为“巍”字牌。公司生产的专治青少年近视、假性近视和近距离用眼疲劳的、以用大理地区主产的白族药紫坚伦为主要原料生产的近视乐眼药水和专治甲肝、乙肝、脂肪肝等多种肝病的傣族药叶下珠片,也是公司的主要产品,目前已销到全国各地。其中近视乐眼药水为我公司的原研产品,已获得中药品种保护。

公司热忱欢迎海内外一切有志于发展中药制药事业的法人、自然人前来对现有产品进行投资合作生产、产品地区销售代理;进一步研制开发中成药系列新产品,做大做强我公司的中药制药事业。

Zijianlun, a Bai nationality medicine mainly produced in Dali area, is the main raw material for the production of myopic eye drops, which is well-known in the industry and a designated national product manufacturer. Founded in 1969 in the south of Yunnan Guizhou Plateau, Dali Bai Autonomous Prefecture traditional Chinese Medicine Pharmaceutical Co., Ltd., formerly known as Dali Bai Autonomous Prefecture traditional Chinese medicine pharmaceutical factory, enjoys the reputation of "wind, flowers, snow and moon". In 2002, it was restructured into a limited liability company controlled by the chairman of the board of directors. In December 2003, the company passed the GMP certification and acceptance, covering an area of more than 15000 square meters, reaching the GMP purification workshop of 1950 square meters, and the warehouse building area of more than 8000 square meters. The credit rating of the enterprise has been recognized by the bank as AA. At present, the company has nearly 200 employees and 31 retired employees, 36 of whom are technicians, including 3 senior pharmaceutical engineers and 15 engineers. In December 2008, it successfully passed the second round of GMP certification acceptance. Before this certification and acceptance, our company on the one hand invested a lot of funds in the transformation and introduction of plant and equipment, on the other hand, focused on the in-depth adjustment and improvement of the software to make it more operable. At present, the company has 43 kinds of state drug approved and registered by the State Food and drug administration, which are divided into nine dosage forms: tablet, tincture, eyedrop, capsule, syrup, ointment, powder, liquor and granule. The registered trademark of the product is "Wei" brand. The company's main products are myopic eye drops, which are mainly made of zijianlun, a Bai nationality medicine produced in Dali, and ye Xiazhu tablets, which are also the company's main products, which are specialized in treating juvenile myopia, pseudomyopia and near-range eye fatigue. At present, they have been sold all over the country. Among them, myopic eye drops are the original research products of our company, which have been protected by traditional Chinese medicine. The company warmly welcomes all legal persons and natural persons at home and abroad who are willing to develop the pharmaceutical industry of traditional Chinese medicine to come to invest and cooperate in the production of existing products, and to sell and act as sales agents in product areas; to further develop new products of traditional Chinese medicine series, and to make our company's pharmaceutical industry of traditional Chinese medicine bigger and stronger.

本文链接: https://brand.waitui.com/d9640a022.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

山西汾酒:股东华创鑫睿计划减持不超1.33%公司股份

36氪获悉,山西汾酒发布公告,根据联和基金相关合作协议,其面临基金到期退出安排,需要减持其间接持有的全部公司股份,因此持股5%以上股东华创鑫睿本次拟通过大宗交易方式减持不超过1620.06万股(含本数),计划减持比例不超过1.33%;自本次减持计划公开披露之日起15个交易日后的3个月内(含3个月期满当日)实施。

45分钟前

中信证券:三方面的技术趋势将推动刻蚀设备的用量和重要性提升

36氪获悉,中信证券预计,至少以下三方面的技术趋势将推动刻蚀设备的用量和重要性提升:1.光刻多重图案化路线的采用;2.三维堆叠存储和近存计算需求;3.底层晶体管结构升级。长期看,半导体设备国产化方向明确,短期来看,下游扩产有望驱动行业进入新一轮增长期。建议关注国内刻蚀设备厂商以及相关配套设备、零部件企业机会。

45分钟前

中信证券:右侧趋势品种继续聚焦资源、消费电子、创新药和游戏

36氪获悉,中信证券研报表示,目前整体的行业选择框架依然是围绕资源+新质生产力+出海。资源股在供给受限以及全球地缘动荡的预期推动下,从周期属性转向偏红利属性会带来估值体系重构,博弈美联储降息的资金退潮带来的波动可以忽略。更大的中期线索还是中国制造业龙头的全球化,将份额优势转化为定价权和利润率提升,带来超越本国经济基本面的市值增长,从而逐步打破行情与基本面背离且全靠流动性驱动的错误认知。配置结构上,保持定力,右侧趋势品种继续聚焦资源、消费电子、创新药和游戏;左侧配置关注化工和军工;产业趋势层面,近期重点关注AI从云侧逻辑开始向端侧逻辑扩散。

45分钟前

环球印务:股东香港原石拟减持不超1%公司股份

36氪获悉,环球印务发布公告,持股10.98%的股份的股东香港原石国际有限公司(简称“香港原石”)计划以集中竞价交易合计减持不超过320.04万股公司股份,占公司总股本比例的1%。

45分钟前

冠中生态:筹划控制权变更事项,股票停牌

36氪获悉,冠中生态发布公告,公司控股股东青岛冠中投资集团有限公司及实际控制人李春林和许剑平正在筹划公司控制权变更相关事宜,可能导致公司控股股东及实际控制人发生变更。经申请,公司股票及可转换公司债券自2025年9月22日起停牌,预计停牌时间不超过2个交易日。停牌期间,公司可转换公司债券“冠中转债”将暂停转股。

45分钟前

本页详细列出关于近视乐的品牌信息,含品牌所属公司介绍,近视乐所处行业的品牌地位及优势。
咨询